Impact of APOL1 Genetic Variants on HIV-1 Infection and Disease Progression

Apolipoprotein L1 (APOL1) has broad innate immune functions and has been shown to restrict HIV replication in vitro by multiple mechanisms. Coding variants in APOL1 are strongly associated with HIV-associated nephropathy (HIVAN) in persons with untreated HIV infection; however, the mechanism by which APOL1 variant protein potentiates renal injury in the presence of high viral load is not resolved. Little is known about the association of APOL1 genotypes with HIV viral load, HIV acquisition, or progression to AIDS. We assessed the role of APOL1 coding variants on HIV-1 acquisition using the conditional logistic regression test, on viral load using the t-test or ANOVA, and on progression to AIDS using Cox proportional hazards models among African Americans enrolled in the ALIVE HIV natural history cohort (n = 775). APOL1 variants were not associated with susceptibility to HIV-1 acquisition by comparing genotype frequencies between HIV-1 positive and exposed or at-risk HIV-1 uninfected groups (recessive model, 12.8 vs. 12.5%, respectively; OR 1.02, 95% CI 0.62–1.70). Similar null results were observed for dominant and additive models. APOL1 variants were not associated with HIV-1 viral load or with risk of progression to AIDS [Relative hazards (RH) 1.33, 95% CI 0.30–5.89 and 0.96, 95% CI 0.49–1.88, for recessive and additive models, respectively]. In summary, we found no evidence that APOL1 variants are associated with host susceptibility to HIV-1 acquisition, set-point HIV-1 viral load or time to incident AIDS. These results suggest that APOL1 variants are unlikely to influence HIV infection or progression among individuals of African ancestry

Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia

Human APOBEC3 cytidine deaminases are intrinsic resistance factors to HIV-1. However, HIV-1 encodes a viral infectivity factor (Vif) that degrades APOBEC3 proteins. In vitro APO-BEC3F (A3F) anti-HIV-1 activity is weaker than A3G but is partially resistant to Vif degradation unlike A3G. It is unknown whether A3F protein affects HIV-1 disease in vivo. To assess the effect of A3F gene on host susceptibility to HIV-acquisition and disease progression, we performed a genetic association study in six well-characterized HIV-1 natural cohorts. A common six-Single Nucleotide Polymorphism (SNP) haplotype of A3F tagged by a codon-changing variant (p. I231V, with allele (V) frequency of 48% in European Americans) was associated with significantly lower set-point viral load and slower rate of progression to AIDS (Relative Hazards (RH) = 0.71, 95% CI: 0.56, 0.91) and delayed development of pneumocystis pneumonia (PCP) (RH = 0.53, 95% CI: 0.37-0.76). A validation study in the International Collaboration for the Genomics of HIV (ICGH) showed a consistent association with lower set-point viral load. An in vitro assay revealed that the A3F I231V variant may influence Vif mediated A3F degradation. Our results provide genetic epidemiological evidence that A3F modulates HIV-1/AIDS disease progression

Neonatal mortality: an invisible and marginalised trauma

Neonatal mortality is a major health problem in low and middle income countries and the rate of improvement of newborn survival is slow. This article is a review of the PhD thesis by Mats Målqvist, titled ‘Who can save the unseen – Studies on neonatal mortality in Quang Ninh province, Vietnam,’ from Uppsala University. The thesis aims to investigate structural barriers to newborn health improvements and determinants of neonatal death. The findings reveal a severe under-reporting of neonatal deaths in the official health statistics in Quang Ninh province in northern Vietnam. The neonatal mortality rate (NMR) found was four times higher than what was reported to the Ministry of Health. This underestimation of the problem inhibits adequate interventions and efforts to improve the survival of newborns and highlights the invisibility of this vulnerable group

Metabolic engineering to simultaneously activate anthocyanin and proanthocyanidin biosynthetic pathways in Nicotiana spp

[EN] Proanthocyanidins (PAs), or condensed tannins, are powerful antioxidants that remove harmful free oxygen radicals from cells. To engineer the anthocyanin and proanthocyanidin biosynthetic pathways to de novo produce PAs in two Nicotiana species, we incorporated four transgenes to the plant chassis. We opted to perform a simultaneous transformation of the genes linked in a multigenic construct rather than classical breeding or retransformation approaches. We generated a GoldenBraid 2.0 multigenic construct containing two Antirrhinum majus transcription factors (AmRosea1 and AmDelila) to upregulate the anthocyanin pathway in combination with two Medicago truncatula genes (MtLAR and MtANR) to produce the enzymes that will derivate the biosynthetic pathway to PAs production. Transient and stable transformation of Nicotiana benthamiana and Nicotiana tabacum with the multigenic construct were respectively performed. Transient expression experiments in N. benthamiana showed the activation of the anthocyanin pathway producing a purple color in the agroinfiltrated leaves and also the effective production of 208.5 nmol (-) catechin/g FW and 228.5 nmol (-) epicatechin/g FW measured by the p-dimethylaminocinnamaldehyde (DMACA) method. The integration capacity of the four transgenes, their respective expression levels and their heritability in the second generation were analyzed in stably transformed N. tabacum plants. DMACA and phoroglucinolysis/HPLC-MS analyses corroborated the activation of both pathways and the effective production of PAs in T0 and T1 transgenic tobacco plants up to a maximum of 3.48 mg/g DW. The possible biotechnological applications of the GB2.0 multigenic approach in forage legumes to produce "bloatsafe" plants and to improve the efficiency of conversion of plant protein into animal protein (ruminal protein bypass) are discussed.This work was supported by grants BIO2012-39849-C02-01 and BIO2016-75485-R from the Spanish Ministry of Economy and Competitiveness (MINECO) (http://www.idi.mineco.gob.es/portal/site/MICINN) to LAC and a fellowship of the JAE-CSIC program to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Fresquet-Corrales, S.; Roque Mesa, EM.; Sarrión-Perdigones, A.; Rochina, M.; López-Gresa, MP.; Díaz-Mula, HM.; Belles Albert, JM.... (2017). Metabolic engineering to simultaneously activate anthocyanin and proanthocyanidin biosynthetic pathways in Nicotiana spp. PLoS ONE. 12(9). https://doi.org/10.1371/journal.pone.0184839Se018483912

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells.

We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating global sequence data. Several variants within nucleocapsid and ORF3a epitopes have arisen independently in multiple lineages and result in loss of recognition by epitope-specific T cells assessed by IFN-γ and cytotoxic killing assays. Complete loss of T cell responsiveness was seen due to Q213K in the A∗01:01-restricted CD8+ ORF3a epitope FTSDYYQLY207-215; due to P13L, P13S, and P13T in the B∗27:05-restricted CD8+ nucleocapsid epitope QRNAPRITF9-17; and due to T362I and P365S in the A∗03:01/A∗11:01-restricted CD8+ nucleocapsid epitope KTFPPTEPK361-369. CD8+ T cell lines unable to recognize variant epitopes have diverse T cell receptor repertoires. These data demonstrate the potential for T cell evasion and highlight the need for ongoing surveillance for variants capable of escaping T cell as well as humoral immunity.This work is supported by the UK Medical Research Council (MRC); Chinese Academy of Medical Sciences(CAMS) Innovation Fund for Medical Sciences (CIFMS), China; National Institute for Health Research (NIHR)Oxford Biomedical Research Centre, and UK Researchand Innovation (UKRI)/NIHR through the UK Coro-navirus Immunology Consortium (UK-CIC). Sequencing of SARS-CoV-2 samples and collation of data wasundertaken by the COG-UK CONSORTIUM. COG-UK is supported by funding from the Medical ResearchCouncil (MRC) part of UK Research & Innovation (UKRI),the National Institute of Health Research (NIHR),and Genome Research Limited, operating as the Wellcome Sanger Institute. T.I.d.S. is supported by a Well-come Trust Intermediate Clinical Fellowship (110058/Z/15/Z). L.T. is supported by the Wellcome Trust(grant number 205228/Z/16/Z) and by theUniversity of Liverpool Centre for Excellence in Infectious DiseaseResearch (CEIDR). S.D. is funded by an NIHR GlobalResearch Professorship (NIHR300791). L.T. and S.C.M.are also supported by the U.S. Food and Drug Administration Medical Countermeasures Initiative contract75F40120C00085 and the National Institute for Health Research Health Protection Research Unit (HPRU) inEmerging and Zoonotic Infections (NIHR200907) at University of Liverpool inpartnership with Public HealthEngland (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford.L.T. is based at the University of Liverpool. M.D.P. is funded by the NIHR Sheffield Biomedical ResearchCentre (BRC – IS-BRC-1215-20017). ISARIC4C is supported by the MRC (grant no MC_PC_19059). J.C.K.is a Wellcome Investigator (WT204969/Z/16/Z) and supported by NIHR Oxford Biomedical Research Centreand CIFMS. The views expressed are those of the authors and not necessarily those of the NIHR or MRC

The transcriptomics of an experimentally evolved plant-virus interaction

[EN] Models of plant-virus interaction assume that the ability of a virus to infect a host genotype depends on the matching between virulence and resistance genes. Recently, we evolved tobacco etch potyvirus (TEV) lineages on different ecotypes of Arabidopsis thaliana, and found that some ecotypes selected for specialist viruses whereas others selected for generalists. Here we sought to evaluate the transcriptomic basis of such relationships. We have characterized the transcriptomic responses of five ecotypes infected with the ancestral and evolved viruses. Genes and functional categories differentially expressed by plants infected with local TEV isolates were identified, showing heterogeneous responses among ecotypes, although significant parallelism existed among lineages evolved in the same ecotype. Although genes involved in immune responses were altered upon infection, other functional groups were also pervasively over-represented, suggesting that plant resistance genes were not the only drivers of viral adaptation. Finally, the transcriptomic consequences of infection with the generalist and specialist lineages were compared. Whilst the generalist induced very similar perturbations in the transcriptomes of the different ecotypes, the perturbations induced by the specialist were divergent. Plant defense mechanisms were activated when the infecting virus was specialist but they were down-regulated when infecting with generalist.We thank Francisca de la Iglesia and Paula Agudo for excellent technical assistance and our labmates for useful discussions and suggestions. This work was supported by grants BFU2012-30805 from the Spanish Ministry of Economy and Competitiveness (MINECO), PROMETEOII/2014/021 from Generalitat Valenciana and EvoEvo (ICT610427) from the European Commission 7th Framework Program to SFE, and grant PROMETEOII/2014/025 to JD. JMC was supported by a JAE-doc postdoctoral contract from CSIC. JH was recipient of a predoctoral contract from MINECO.Hillung, J.; García-García, F.; Dopazo, J.; Cuevas Torrijos, JM.; Elena Fito, SF. (2016). The transcriptomics of an experimentally evolved plant-virus interaction. Scientific Reports. 6:1-19. https://doi.org/10.1038/srep24901S1196Duffy, S., Shackelton, L. A. & Holmes, E. C. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet. 9, 267–276 (2008).Parrish, C. R. et al. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol. Mol. Biol. Rev. 72, 457–470 (2008).Holmes, E. C. The comparative genomics of viral emergence. Proc. Natl. Acad. Sci. USA 107, 1742–1746 (2010).Sanjuán, R., Nebot, M. R., Chirico, N., Mansky, L. M. & Belshaw, R. Viral mutation rates. J. Virol. 84, 9733–9748 (2010).Elena, S. F. et al. The evolutionary genetics of emerging plant RNA viruses. Mol. Plant-Microbe Interact. 24, 287–293 (2011).Holmes, E. C. The evolutionary genetics of emerging viruses. Annu. Rev. Ecol. Evol. Syst. 40, 353–372 (2009).Domingo, E. Mechanisms of viral emergence. Vet. Res. 41, 38 (2010).King, K. C. & Lively, C. M. Does genetic diversity limit disease spread in natural host populations? Heredity 109, 199–203 (2012).Kearney, C. M., Thomson, M. J. & Roland, K. E. Genome evolution of Tobacco mosaic virus populations during long-term passaging in a diverse range of hosts. Arch. Virol. 144, 1513–1526 (1999).Tan, Z. et al. Mutations in Turnip mosaic virus genomes that have adapted to Raphanus sativus . J. Gen. Virol. 88, 501–510 (2005).Rico, P., Ivars, P., Elena, S. F. & Hernández, C. Insights into the selective pressures restricting Pelargonium flower break virus genome variability: evidence for host adaptation. J. Virol. 80, 8124–8132 (2006).Wallis, C. M. et al. Adaptation of Plum pox virus to a herbaceous host (Pisum sativum) following serial passages. J. Gen. Virol. 88, 2839–2845 (2007).Agudelo-Romero, P., de la Iglesia, F. & Elena, S. F. The pleiotropic cost of host-specialization in tobacco etch potyvirus. Infect. Genet. Evol. 8, 806–814 (2008).Bedhomme, S., Lafforgue, G. & Elena, S. F. Multihost experimental evolution of a plant RNA virus reveals local adaptation and host-specific mutations. Mol. Biol. Evol. 29, 1481–1492 (2012).García-Arenal, F. & Fraile A. Trade-offs in host range evolution of plant viruses. Plant Pathol. 62, S2–S9. (2013).Calvo, M., Malinowski, T. & García, J. A. Single amino acid changes in the 6K1-CI region can promote the alternative adaptation of Prunus- and Nicotiana- propagated Plum pox virus C isolates to either host. Mol. Plant-Microbe Interact. 27, 136–149 (2014).Cuevas, J. M., Willemsen, A., Hillung, J., Zwart, M. P. & Elena, S. F. Temporal dynamics of intra-host molecular evolution for a plant RNA virus. Mol. Biol. Evol. 32, 1132–1147 (2015).Minicka, J., Rymelska, N., Elena, S. F., Czerwoniec, A. & Hasiów-Jaroszewska, B. Molecular evolution of Pepino mosaic virus during long-term passaging in different hosts and its impact on virus virulence. Ann. Appl. Biol. 166, 389–401 (2015).Agudelo-Romero, P., Carbonell, P., Pérez-Amador, M. A. & Elena, S. F. Virus adaptation by manipulation of host's gene expression. PLos ONE 3, e2397 (2008).Weigel, D. Natural variation in arabidopsis: from molecular genetics to ecological genomics. Plant Physiol. 158, 2–22 (2012).Mahajan, S. K., Chisholm, S. T., Whitham, S. A. & Carrington, J. C. Identification and characterization of a locus (RTM1) that restricts long-distance movement of Tobacco etch virus in Arabidopsis thaliana . Plant J. 14, 177–186 (1998).Whitham, S. A., Yamamoto, M. L. & Carrington, J. C. Selectable viruses and altered susceptibility mutants in Arabidopsis thaliana . Proc. Natl. Acad. Sci. USA 96, 772–777 (1999).Whitham, S. A., Anderberg, R. J., Chisholm, S. T. & Carrington, J. C. Arabidopsis RTM2 gene is necessary for specific restriction of Tobacco etch virus and encodes an unusual small heat shock-like protein. Plant Cell 12, 569–582 (2000).Chisholm, S. T., Mahajan, S. K., Whitham, S. A., Yamamoto, M. L. & Carrington, J. C. Cloning of the Arabidopsis RTM1 gene, which controls restriction of long-distance movement of Tobacco etch virus . Proc. Natl. Acad. Sci. USA 97, 489–494 (2000).Chisholm, S. T., Parra, M. A., Anderberg, R. J. & Carrington, J. C. Arabidopsis RTM1 and RTM2 genes function in phloem to restrict long-distance movement of Tobacco etch virus . Plant Physiol. 127, 1667–1675 (2001).Cosson, P. et al. RTM3, which controls long-distance movement of potyviruses, is a member of a new plant gene family encoding a MEPRIN and TRAF homology domain-containing protein. Plant Physiol. 154, 222–232 (2010).Cosson, P., Sofer, L., Schurdi-Levraud, V. & Revers, F. A member of a new plant gene family encoding a MEPRIN and TRAF homology (MATH) domain-containing protein is involved in restriction of long distance movement of plant viruses. Plant Signal. Behav. 5, 1321–1323 (2010).Agudelo-Romero P. et al. Changes in gene expression profile of Arabidopsis thaliana after infection with Tobacco etch virus . Virol. J. 5, 92 (2008).Lalić, J., Agudelo-Romero, P., Carrasco, P. & Elena, S. F. Adaptation of tobacco etch potyvirus to a susceptible ecotype of Arabidopsis thaliana capacitates it for systemic infection of resistant ecotypes. Phil. Trans. R. Soc. B 65, 1997–2008 (2010).Hillung, J., Cuevas, J. M. & Elena, S. F. Transcript profiling of different Arabidopsis thaliana ecotypes in response to tobacco etch potyvirus infection. Front. Microbiol. 3, 229 (2012).Hillung, J., Cuevas, J. M. & Elena, S. F. Evaluating the within-host fitness effects of mutations fixed during virus adaptation to different ecotypes of a new host. Phil. Trans. R. Soc. B 370, 20140292 (2015).Hillung, J., Cuevas, J. M., Valverde, S. & Elena, S. F. Experimental evolution of an emerging plant virus in host genotypes that differ in their susceptibility to infection. Evolution 68, 2467–2480 (2014).Sartor, M. A., Leikauf, G. D. & Medvedovic, M. LRpath: a logistic regression approach for identifying enriched biological groups in gene expression data. Bioinformatics 25, 211–217 (2009).Montaner, D. & Dopazo, J. Multidimensional gene set analysis of genomic data. PLos ONE 5, e10348 (2010).Supek, F., Bosnjak, M., Skunca, N. & Smuc, T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLos ONE 6, e21800 (2011).Grennan, A. K. Regulation of starch metabolism in Arabidopsis leaves. Plant Physiol. 142, 1343–1345 (2006).Johnson, P. R. & Ecker, J. R. The ethylene gas signal transduction pathway: a molecular perspective. Annu. Rev. Genet. 32, 227–254 (1998).Wang, K. L., Li, H. & Ecker, J. R. Ethylene biosynthesis and signaling networks. Plant Cell 14, S131–S151 (2002).Binns, D. et al. QuickGO: a web-based tool for gene ontology searching. Bioinformatics 25, 3045–3046 (2009).Stintzi, A., Weber, H., Reymond, P., Browse, J. & Farmer, E. E. Plant defense in the absence of jasmonic acid: the role of cyclopentenones. Proc. Natl. Acad. Sci. USA 98, 12837–12842 (2001).Luna, E. et al. Callose deposition: a multifaceted plant defense response. Mol. Plant-Microbe Interact. 24, 183–193 (2011).Ghoshroy, S., Freedman, K., Lartey, R. & Citovsky, V. Inhibition of plant viral systemic infection by non-toxic concentrations of cadmium. Plant J. 13, 591–602 (1998).Hayashi, N. et al. Nef of HIV-1 interacts directly with calcium-bound calmodulin. Protein Sci. 11, 529–537 (2002).Zacharias, D. A., Violin, J. D., Newton, A. C. & Tsien, R. Y. Partitioning of lipic-modified monomeric GFPs into membrane microdomains of live cells. Science 296, 913–916 (2002).Rojas, M. R. et al. Functional analysis of proteins involved in movement of the monopartite begomovirus, Tomato yellow leaf curl virus. Virology 291, 110–125 (2001).Padmanabhan, M. S., Goregaoker, S. P., Golem, S., Shiferaw, H. & Culver, J. N. Interaction of the Tobacco mosaic virus replicase protein with the Aux/IAA protein PAP1/IAA26 is associated with disease development. J. Virol. 79, 2549–2558 (2005).Lurin, C. et al. Genome-wide analysis of Arabidopsis pentatricopeptide repeat proteins reveals their essential role in organelle biogenesis. Plant Cell 16, 2089–2103 (2004).Takenaka, M., Verbitskiy, D., Zehrmann, A. & Brennicke, A. Reverse genetic screening identifies five E-class PPR proteins involved in RNA editing in mitochondria of Arabidopsis thaliana . J. Biol. Chem. 285, 27122–27129 (2010).Gillissen, B. et al. A new family of high-affinity transporters for adenine, cytosine, and purine derivatives in Arabidopsis . Plant Cell 12, 291–300 (2000).Li, S., Fu, Q., Chen, L., Huang, W. & Yu, D. Arabidopsis thaliana WRKY25, WRKY26, and WRKY33 coordinate induction of plant thermotolerance. Planta 233, 1237–1252 (2011).Divol, F. et al. Involvement of the xyloglucan endotransglycosylase/hydrolases encoded by celery XTH1 and Arabidopsis XTH33 in the phloem response to aphids. Plant Cell. Environ. 30, 187–201 (2007).Vissenberg, K., Fry, S. C., Pauly, M., Höfte, H. & Verbelen, J. P. XTH acts at the microfibril-matrix interface during cell elongation. J. Exp. Bot. 56, 673–683 (2005).Ham, B. K., Li, G., Kang, B. H., Zeng, F. & Lucas, W. J. Overexpression of Arabidopsis plasmodesmata germin-like proteins disrupts root growth and development. Plant Cell 24, 3630–3648 (2012).Bae, M. S., Cho, E. J., Choi, E. Y. & Park, O. K. Analysis of the Arabidopsis nuclear proteome and its response to cold stress. Plant J. 36, 652–663 (2003).Zargar, S. M. et al. Correlation analysis of proteins responsive to Zn, Mn, or Fe deficiency in Arabidopsis roots based on iTRAQ analysis. Plant Cell Rep. 34, 157–166 (2015).Kleffmann, T. et al. The Arabidopsis thaliana chloroplast proteome reveals pathway abundance and novel protein functions. Curr. Biol. 14, 354–362 (2004).Zybailov, B. et al. Sorting signals, N-terminal modifications and abundance of the chloroplast proteome. PLos ONE 3, e1994 (2008).Wu, P. et al. Phosphate starvation triggers distinct alterations of gene expression in Arabidopsis roots and leaves. Plant Physiol. 132, 1260–1271 (2003).Oh, S. A., Lee, S. Y., Chung, I. K., Lee, C. H. & Nam H. G. A senescence-associated gene of Arabidopsis thaliana is distinctively regulated during natural and artificially induced leaf senescence. Plant Mol. Biol. 30, 739–754 (1996).Schenk, P. M., Kazan, K., Rusu, A. G., Manners, J. M. & Maclean, D. J. The SEN1 gene of Arabidopsis is regulated by signals that link plant defence responses and senescence. Plant Physiol. Biochem. 43, 997–1005 (2005).Fernández-Calvino, L. et al. Activation of senescence-associated dark-inducible (DIN) genes during infection contributes to enhanced susceptibility to plant viruses. Mol. Plant Pathol. 17, 3–15 (2016).Vierstra, R. D. Proteolysis in plants: mechanisms and functions. Plant Mol. Biol. 32, 275–302 (1996).Bögre, L., Okrész, L., Henriques, R. & Anthony, R. G. Growth signalling pathways in Arabidopsis and the AGC protein kinases. Trends Plant Sci. 8, 424–431 (2003).An, L. et al. A zinc finger protein gene ZFP5 integrates phytohormone signalling to control root hair development in Arabidopsis . Plant J. 72, 474–490 (2012).Zhou, Z., An, L., Sun, L. & Gan, Y. ZFP5 encodes a functionally equivalent GIS protein to control trichome initiation. Plant Signal. Behav. 7, 28–30 (2012).Zhou, Z. et al. Zinc finger protein 5 is required for the control of trichome initiation by acting upstream of zinc finger protein 8 in Arabidopsis . Plant Physiol. 157, 673–682 (2011).Lee, D. J. et al. Genome-wide expression profiling of ARABIDOPSIS RESPONSE REGULATOR 7 (ARR7) overexpression in cytokinin response. Mol. Genet. Genomics 277, 115–137 (2007).Theologis, A. et al. Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana . Nature 408, 816–820 (2000).Heyndrickx, K. S. & Vandepoele, K. Systematic identification of functional plant modules through the integration of complementary data sources. Plant Physiol. 159, 884–901 (2012).Martinoia, E. et al. Multifunctionality of plant ABC transporter - more than just detoxifiers. Planta 214, 345–355 (2002).Kaneda, M. et al. ABC transporters coordinately expressed during lignification of Arabidopsis stems include a set of ABCBs associated with auxin transport. J. Exp. Bot. 62, 2063–2077 (2011).Alejandro, S. et al. AtABCG29 is a monolignol transporter involved in lignin biosynthesis. Curr. Biol. 22, 1207–1212 (2012).Riechmann, J. L. et al. Arabidopsis transcription factors: genome-wide comparative analysis among eukaryotes. Science 290, 2105–2110 (2000).Ohashi-Ito, K. & Bergmann, D. C. Regulation of the Arabidopsis root vascular initial population by LONESOME HIGHWAY . Development 134, 2959–2968 (2007).Averyanov, A. Oxidative burst and plant disease resistance. Front. Biosci. 1, 142–152 (2009).Flury, P., Klauser, D., Schulze, B., Boller, T. & Bartels, S. The anticipation of danger: microbe-associated molecular pattern perception enhances AtPep-triggered oxidative burst. Plant Physiol. 161, 2023–2035 (2013).Tanaka, K., Nguyen, C. T., Liang, Y., Cao, Y. & Stacey, G. Role of LysM receptors in chitin-triggered plant innate immunity. Plant Signal. Behav. 8, e22598 (2013).Nakamura, K. & Matsuoka, K. Protein targeting to the vacuole in plant cells. Plant Physiol. 101, 1–5 (1993).Elena, S. F., Agudelo-Romero, P. & Lalić, J. The evolution of viruses in multi-host fitness landscapes. Open Virol. J. 3, 1–6 (2009).Bolstad, B. M., Irizarry, R. A., Astrand, M. & Speed, T. P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185–193 (2003).Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, 3 (2004).Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995).Benjamini,Y. & Yekutieli, D. The control of the false discovery rate in multiple testing under dependency. Ann. Statist. 29, 1165–1188 (2001).Sneath, P. & Sokal, R. Numerical Taxonomy. ( W.H. Freeman, 1973).D'Haeseler, P. How does gene expression clustering work? Nat. Biotech. 23, 1499–1501 (2005).Suzuki, R. & Shimodaira, H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22, 1540–1542 (2006)

Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021

This paper uses a robust method of spatial epidemiological analysis to assess the spatial growth rate of multiple lineages of SARS-CoV-2 in the local authority areas of England, September 2020–December 2021. Using the genomic surveillance records of the COVID-19 Genomics UK (COG-UK) Consortium, the analysis identifies a substantial (7.6-fold) difference in the average rate of spatial growth of 37 sample lineages, from the slowest (Delta AY.4.3) to the fastest (Omicron BA.1). Spatial growth of the Omicron (B.1.1.529 and BA) variant was found to be 2.81× faster than the Delta (B.1.617.2 and AY) variant and 3.76× faster than the Alpha (B.1.1.7 and Q) variant. In addition to AY.4.2 (a designated variant under investigation, VUI-21OCT-01), three Delta sublineages (AY.43, AY.98 and AY.120) were found to display a statistically faster rate of spatial growth than the parent lineage and would seem to merit further investigation. We suggest that the monitoring of spatial growth rates is a potentially valuable adjunct to outbreak response procedures for emerging SARS-CoV-2 variants in a defined population

Tracking SARS-CoV-2 mutations and variants through the COG-UK-Mutation Explorer

COG-UK Mutation Explorer (COG-UK-ME, https://sars2.cvr.gla.ac.uk/cog-uk/—last accessed date 16 March 2022) is a web resource that displays knowledge and analyses on SARS-CoV-2 virus genome mutations and variants circulating in the UK, with a focus on the observed amino acid replacements that have an antigenic role in the context of the human humoral and cellular immune response. This analysis is based on more than 2 million genome sequences (as of March 2022) for UK SARS-CoV-2 data held in the CLIMB-COVID centralised data environment. COG-UK-ME curates these data and displays analyses that are cross-referenced to experimental data collated from the primary literature. The aim is to track mutations of immunological importance that are accumulating in current variants of concern and variants of interest that could alter the neutralising activity of monoclonal antibodies (mAbs), convalescent sera, and vaccines. Changes in epitopes recognised by T cells, including those where reduced T cell binding has been demonstrated, are reported. Mutations that have been shown to confer SARS-CoV-2 resistance to antiviral drugs are also included. Using visualisation tools, COG-UK-ME also allows users to identify the emergence of variants carrying mutations that could decrease the neutralising activity of both mAbs present in therapeutic cocktails, e.g. Ronapreve. COG-UK-ME tracks changes in the frequency of combinations of mutations and brings together the curated literature on the impact of those mutations on various functional aspects of the virus and therapeutics. Given the unpredictable nature of SARS-CoV-2 as exemplified by yet another variant of concern, Omicron, continued surveillance of SARS-CoV-2 remains imperative to monitor virus evolution linked to the efficacy of therapeutics

SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2

Background: Since the emergence of SARS-CoV-2, evolutionary pressure has driven large increases in the transmissibility of the virus. However, with increasing levels of immunity through vaccination and natural infection the evolutionary pressure will switch towards immune escape. Genomic surveillance in regions of high immunity is crucial in detecting emerging variants that can more successfully navigate the immune landscape. Methods: We present phylogenetic relationships and lineage dynamics within England (a country with high levels of immunity), as inferred from a random community sample of individuals who provided a self-administered throat and nose swab for rt-PCR testing as part of the REal-time Assessment of Community Transmission-1 (REACT-1) study. During round 14 (9 September–27 September 2021) and 15 (19 October–5 November 2021) lineages were determined for 1322 positive individuals, with 27.1% of those which reported their symptom status reporting no symptoms in the previous month. Results: We identified 44 unique lineages, all of which were Delta or Delta sub-lineages, and found a reduction in their mutation rate over the study period. The proportion of the Delta sub-lineage AY.4.2 was increasing, with a reproduction number 15% (95% CI 8–23%) greater than the most prevalent lineage, AY.4. Further, AY.4.2 was less associated with the most predictive COVID-19 symptoms (p = 0.029) and had a reduced mutation rate (p = 0.050). Both AY.4.2 and AY.4 were found to be geographically clustered in September but this was no longer the case by late October/early November, with only the lineage AY.6 exhibiting clustering towards the South of England. Conclusions: As SARS-CoV-2 moves towards endemicity and new variants emerge, genomic data obtained from random community samples can augment routine surveillance data without the potential biases introduced due to higher sampling rates of symptomatic individuals. © 2022, The Author(s)

Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

Summary Background The first epidemic wave of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in Scotland resulted in high case numbers and mortality in care homes. In Lothian, over one-third of care homes reported an outbreak, while there was limited testing of hospital patients discharged to care homes. Aim To investigate patients discharged from hospitals as a source of SARS-CoV-2 introduction into care homes during the first epidemic wave. Methods A clinical review was performed for all patients discharges from hospitals to care homes from 1st March 2020 to 31st May 2020. Episodes were ruled out based on coronavirus disease 2019 (COVID-19) test history, clinical assessment at discharge, whole-genome sequencing (WGS) data and an infectious period of 14 days. Clinical samples were processed for WGS, and consensus genomes generated were used for analysis using Cluster Investigation and Virus Epidemiological Tool software. Patient timelines were obtained using electronic hospital records. Findings In total, 787 patients discharged from hospitals to care homes were identified. Of these, 776 (99%) were ruled out for subsequent introduction of SARS-CoV-2 into care homes. However, for 10 episodes, the results were inconclusive as there was low genomic diversity in consensus genomes or no sequencing data were available. Only one discharge episode had a genomic, time and location link to positive cases during hospital admission, leading to 10 positive cases in their care home. Conclusion The majority of patients discharged from hospitals were ruled out for introduction of SARS-CoV-2 into care homes, highlighting the importance of screening all new admissions when faced with a novel emerging virus and no available vaccine